Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With Aqp4-Igg-Positive Nmosd Publisher Pubmed



Siriratnam P1 ; Huda S1 ; Van Der Walt A1 ; Sanfilippo PG1 ; Sharmin S1 ; Foong YC1 ; Yeh WZ1 ; Zhu C1 ; Khoury SJ1 ; Csepany T1 ; Willekens B1 ; Etemadifar M1 ; Ozakbas S1 ; Nytrova P1 Show All Authors
Authors
  1. Siriratnam P1
  2. Huda S1
  3. Van Der Walt A1
  4. Sanfilippo PG1
  5. Sharmin S1
  6. Foong YC1
  7. Yeh WZ1
  8. Zhu C1
  9. Khoury SJ1
  10. Csepany T1
  11. Willekens B1
  12. Etemadifar M1
  13. Ozakbas S1
  14. Nytrova P1
  15. Altintas A1
  16. Alasmi A1
  17. Ramotello CM1
  18. Laureys G1
  19. Patti F1
  20. Horakova D1
  21. Foschi M1
  22. Boz C1
  23. Mccombe PA1
  24. Turkoglu R1
  25. Lechnerscott J1
  26. Roos I1
  27. Kalincik T1
  28. Jokubaitis VG1
  29. Butzkueven H1
  30. Monif M1
Show Affiliations
Authors Affiliations
  1. 1. From the Department of Neuroscience (P.S., A.V.D.W., P.G.S., Y.C.F., W.Z.Y., C.Z., V.G.J., H.B., M.M.), Central Clinical School, Monash University, Melbourne, Victoria
  2. 2. Department of Neurology (P.S., A.V.D.W., P.G.S., Y.C.F., W.Z.Y., V.G.J., H.B., M.M.), Alfred Health, Melbourne, Victoria, Australia
  3. 3. Department of Neurology (P.S., S.H.), Walton Centre NHS Foundation Trust, Liverpool, United Kingdom
  4. 4. Neuroimmunology Centre (S.S., I.R., T.K.), Department of Neurology, The Royal Melbourne Hospital, Parkville
  5. 5. CORe (S.S., I.R., T.K.), Department of Medicine, University of Melbourne, Victoria
  6. 6. Royal Hobart Hospital (Y.C.F.), Hobart, Tasmania, Australia
  7. 7. Nehme and Therese Tohme Multiple Sclerosis Center (S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon
  8. 8. Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary
  9. 9. Department of Neurology (B.W.), Antwerp University Hospital, Edegem
  10. 10. Translational Neurosciences Research Group (B.W.), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium
  11. 11. Faculty of Medicine (M.E.), Isfahan University of Medical Sciences
  12. 12. Neurology (M.E.), Dr. Etemadifar MS Institute, Isfahan, Iran
  13. 13. Izmir University of Economics (S.O.), Medical Point Hospital
  14. 14. Multiple Sclerosis Research Association (S.O.), Izmir, Turkey

Source: Neurology Published:2024


Abstract

OBJECTIVES: In aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-IgG NMOSD), disability accrual is mostly attributed to relapses. This study aimed to assess the prevalence of progression independent of relapse activity (PIRA) and relapse-associated worsening (RAW) in AQP4-IgG NMOSD. METHODS: This was a retrospective cohort study of patients with AQP4-IgG NMOSD enrolled in the MSBase international data registry. Patients required a minimum of 3 recorded Expanded Disability Status Scale (EDSS) scores: baseline, event, and a 6-month confirmation score. Presence and absence of relapses between the baseline and event EDSS scores determined RAW and PIRA, respectively. Descriptive statistics were used to present the results. RESULTS: A total of 181 patients followed for a median of 4.5 years (Q1 1.7, Q3 7.8) were included. Most patients were female (88.4%), and the median age at disease onset was 38.1 years. Overall, 4 patients (2.2%) developed 5 incidences of PIRA and 13 patients developed RAW (7.2%). DISCUSSION: This multicenter study highlights that PIRA is very rare in AQP4-IgG NMOSD. Limitations of this study include the sole focus of overall EDSS to measure disability, lack of requirement for a second EDSS score to confirm baseline EDSS, and the absence of magnetic resonance imaging information for all patients.
Other Related Docs
15. Retinal Optical Coherence Tomography in Neuromyelitis Optica, Neurology: Neuroimmunology and NeuroInflammation (2021)
22. Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum Disorders, Neurology: Neuroimmunology and NeuroInflammation (2024)
23. Whole Spinal Transverse Myelitis in Neuromyelitis Optica Spectrum Disorder, Multiple Sclerosis and Related Disorders (2024)
25. Frequency of Diencephalic Syndrome in Nmosd, Acta Neurologica Belgica (2022)
40. Diagnosis and Classification of Optic Neuritis, The Lancet Neurology (2022)
41. Efficacy and Safety of Rituximab in Neuromyelitis Optica: Review of Evidence, Journal of Research in Medical Sciences (2017)
48. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2016)
49. Mri Signs of Cns Demyelinating Diseases, Multiple Sclerosis and Related Disorders (2021)